Showing 12,641 - 12,660 results of 35,226 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 1.13s Refine Results
  1. 12641
  2. 12642

    S2 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  3. 12643

    S1 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  4. 12644

    S1 Data - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  5. 12645

    S5 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  6. 12646

    S4 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  7. 12647

    S3 Fig - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  8. 12648

    S1 File - by Xinyue Yang (629144)

    Published 2024
    “…On day 8, the rats were transferred to a simulated climate cabin, At 0, 50, 100, and 150 min, the core temperature (Tc) was measured respectively. …”
  9. 12649
  10. 12650
  11. 12651
  12. 12652
  13. 12653
  14. 12654
  15. 12655
  16. 12656

    DataSheet_1_A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in health... by Richard T. Kenney (15289313)

    Published 2024
    “…</p>Methods<p>SB102 (NCT05408572) focused on safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) endpoints. SON-1010 at 50-300 ng/kg or placebo administered subcutaneously on day 1 was studied at a ratio of 6:2, starting with two sentinels; participants were followed through day 29. …”
  17. 12657
  18. 12658
  19. 12659
  20. 12660